Neimeth International Pharmaceuticals Plc has announced a 103 per cent growth in revenue for the 2024 financial year, as shareholders expressed confidence in the company’s performance and future profitability during its 66th Annual General Meeting held on Monday in Lagos. The company’s Chairman, Christopher Oshiafi, disclosed this while presenting the audited financial results for the...
Read more